Healthy Clinical Trial
— COVER-HCWOfficial title:
Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19)
| Verified date | April 2024 |
| Source | RAND |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Study to support the mental and physical well-being of US health care workers during the COVID-19 pandemic and ensure high-quality care for patients through Stress First Aid.
| Status | Completed |
| Enrollment | 2077 |
| Est. completion date | July 29, 2022 |
| Est. primary completion date | July 29, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - Health care workers and patient-facing support staff (e.g., front desk staff) Exclusion Criteria: - Non-English speaking |
| Country | Name | City | State |
|---|---|---|---|
| United States | Vizient Inc. | Irving | Texas |
| United States | Clinical Directors Network, Inc | New York | New York |
| Lead Sponsor | Collaborator |
|---|---|
| RAND | Clinical Directors Network, Stanford University, Vizient |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Posttraumatic Stress Disorder (PTSD) | Posttraumatic Stress Checklist (PCL); a Diagnostic and Statistical Manual of Mental Disorders a 20-item measure of PTSD symptoms rated on 0-4 frequency scale | Pre-SFA intervention: months 1 to 2 | |
| Primary | PTSD | Posttraumatic Stress Checklist (PCL); a Diagnostic and Statistical Manual of Mental Disorders a 20-item measure of PTSD symptoms rated on 0-4 frequency scale | Post-SFA intervention: months 3 to 5 | |
| Primary | Psychological Distress | Kessler 6 Distress Scale (K-6) for general psychological distress. This is a 6-item inventory rated on a 5 point Likert-type scale. | Pre-SFA intervention: months 1 to 2 | |
| Primary | Psychological Distress | Kessler 6 Distress Scale (K-6) for general psychological distress. This is a 6-item inventory rated on a 5 point Likert-type scale. | Post-SFA intervention: months 3 to 5 | |
| Secondary | Sleep Impairment | PROMIS Sleep Related Impairment. A 4-item subscale which is rated from 1-5 (not at all to very much). | Pre-SFA intervention: months 1 to 2 | |
| Secondary | Sleep Impairment | PROMIS Sleep Related Impairment. A 4-item subscale which is rated from 1-5 (not at all to very much). | Post-SFA intervention: months 3 to 5 | |
| Secondary | Workplace stress | American Psychological Association's Stress in the Workplace survey; 3 items rated on a 1-5 scale from strongly disagree to strongly agree | Pre-SFA intervention: months 1 to 2 | |
| Secondary | Workplace stress | American Psychological Association's Stress in the Workplace survey; 3 items rated on a 1-5 scale from strongly disagree to strongly agree | Post-SFA intervention: months 3 to 5 | |
| Secondary | Resilience | Connor Davidson Resilience Scale (CDRISC); a brief (2-item) version of the scale, rated from 1-5 (not true at all to true nearly all the time) | Pre-SFA intervention: months 1 to 2 | |
| Secondary | Resilience | Connor Davidson Resilience Scale (CDRISC); a brief (2-item) version of the scale, rated from 1-5 (not true at all to true nearly all the time) | Post-SFA intervention: months 3 to 5 | |
| Secondary | Burnout | Dolan single item burnout inventory; participants choose the description of burnout level that reflects their experience. | Pre-SFA intervention: months 1 to 2 | |
| Secondary | Burnout | Dolan single item burnout inventory; participants choose the description of burnout level that reflects their experience. | Post-SFA intervention: months 3 to 5 | |
| Secondary | Moral Distress | Moral Distress Thermometer; single item Sliding scale with responses rated on a 0-10 scale from none to worst possible. | Pre-SFA intervention: months 1 to 2 | |
| Secondary | Moral Distress | Moral Distress Thermometer; single item Sliding scale with responses rated on a 0-10 scale from none to worst possible. | Post-SFA intervention: months 3 to 5 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |